FBC
LLY icon

Fairfield, Bush & Co’s Eli Lilly LLY Stock Holding History

Fairfield, Bush & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400
Closed -$129K – 123
2022
Q3 		$129K Buy
+400
New +$127K 0.09% 115

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fairfield, Bush & Co's LLY Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Eli Lilly (LLY) stake by 0.14% in Q1 2026, selling an estimated $4.05K and leaving 2,837 shares worth $2.61M. The position accounts for 1.45% of the portfolio, ranked #21.

Fairfield, Bush & Co first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.4M in Q2 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fairfield, Bush & Co held 2,837 shares of Eli Lilly worth $2.61M as of Q1 2026.
  • Fairfield, Bush & Co sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 1.45% of Fairfield, Bush & Co's portfolio in Q1 2026, its #21 holding.
  • Fairfield, Bush & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Fairfield, Bush & Co's Eli Lilly position peaked at $12.4M in Q2 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.